Melanie Lee
Director/Board Member at UK DRI Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
José Redondo | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Lars Søren Rasmussen | M | 65 | 11 years | |
António Mota Horta-Osorio | M | 60 |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Miguel Luis Portela | M | 46 |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Emile Voest | M | 64 | 2 years | |
Mark Hardy | M | 70 |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | 20 years |
Paul Hudson | M | 56 | 5 years | |
Barbara Lavernos | F | 56 | 3 years | |
Carole Ferrand | F | 53 | 2 years | |
Antoine Yver | M | 66 | 2 years | |
Max Bricchi | M | 51 |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | 1 years |
Daniel Bessa | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Madeleine Roach | F | 40 | 2 years | |
Lene Skole-Sørensen | F | 65 | 9 years | |
António Portela | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Rachel Duan | F | 52 | 4 years | |
Lise Kingo | F | 62 | 4 years | |
Gilles Schnepp | M | 64 | 4 years | |
Lars Erik Holmqvist | M | 64 | 9 years | |
Julie van Ongevalle | F | 49 | 4 years | |
Yann Tran | M | 58 | 3 years | |
Wolfgang Laux | M | 56 | 3 years | |
Raj Verma | M | - | 4 years | |
Joanne Pisani | F | 59 |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Terri Cooper | M | - |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | 1 years |
José Carlos da Silva Cardoso | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Patrícia Andrea Teixeira Lopes Couto Viana | F | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Luís Miguel da Rocha | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Sameer Mistry | M | - |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | 1 years |
Antonio Chow | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | 9 years |
Mark McDade | M | 69 |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | 16 years |
Carol Routledge | M | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Dietmar Berger | M | - | 5 years | |
David M. Zahn | M | - |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | 5 years |
Richard Pilnik | M | 67 |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Susana Vasconcelos | M | - |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | - |
Natalie Bickford | F | 53 | 4 years | |
Roy Papatheodorou | M | 46 | 2 years | |
Iain Alasdair Keith Moodie | M | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Rima Makarem | M | 55 |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | 1 years |
Nancy Jane Rothwell | F | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Anne Jane Shevas | F | 68 |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
William Rucker | M | 60 |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Lynne Robb | F | - |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | 4 years |
Adrian Ivinson | M | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Robin Stuart Buckle | M | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Fiona Mary Carragher | F | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Jo Patra Pisani | M | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | - |
Christophe Babule | M | 58 | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mats Gunnar Pettersson | M | 78 | 10 years | |
Susan Foden | M | 71 | - | |
Terrie Curran | F | 55 | 3 years | |
Caroline Luscombe | F | 64 | 2 years | |
Andreas Eggert | M | 56 | 5 years | |
Jeffrey Klimaski | M | - | - | |
Mishima Gerhart | F | - | 6 years | |
Ulf Arne Wiinberg | M | 66 | 6 years | |
Emmanuel Babeau | M | 57 | 2 years | |
Suet-Fern Lee | F | 66 | 9 years | |
Peter Henrik Kürstein-Jensen | M | 68 | 11 years | |
Claudie Haigneré | M | 67 | 12 years | |
Rolf Soderstrom | M | 58 | 10 years | |
John Brown | M | 69 | 4 years | |
Greg Barrett | M | 70 | 2 years | |
Robert Castaigne | M | 78 | 18 years | |
Carole Piwnica | F | 66 | 12 years | |
Bernard Charlès | M | 66 | - | |
Graham Hetherington | M | 65 | 3 years | |
Jens Jesper Ovesen | M | 67 | 3 years | |
Peter William Stratford | M | 60 | - | |
Peter Chambré | M | 68 | 6 years | |
Richard Leslie Martin Wohanka | M | 71 | - | |
Olivier Brandicourt | M | 68 | 4 years | |
Chris Freitag | M | 58 | 2 years | |
Guillaume Rosso | M | - | 5 years | |
Sarah Holland | F | 61 | 2 years | |
Antoine Delcour | M | - | 6 years | |
Christine Whyte | M | - |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | 5 years |
Klaus Jensen | M | 51 | 3 years | |
Ruchita Sinha | F | - | 3 years | |
Noel Geoffroy | F | 52 | 3 years | |
Hitto Kaufmann | M | 53 | 1 years | |
Colin Sims | M | - | 1 years | |
Quentin Vivant | M | - | - | |
Karen Linehan | F | 65 | 25 years | |
Stefan Oelrich | M | 55 | 7 years | |
Mahalakshmi Radhakrishnan | M | - | 3 years | |
Ameet Nathwani | M | 60 | 4 years | |
Riccardo Perfetti | M | 64 | 11 years | |
Eva Schäfer-Jansen | F | - | - | |
Jean-Baptiste Chasseloup de Chatillon | M | 59 | 6 years | |
William Sibold | M | - | 6 years | |
Roberto Pucci | M | 60 | 9 years | |
Celia Caulcott | M | - |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | - |
David D. McConnell | M | - |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | - |
John Reed | M | 65 | 5 years | |
David K. Newbigging | M | 90 |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | - |
William John Robinson | M | 76 |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | - |
Jean-Philippe Collin | M | 67 | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 46 | 46.46% |
United Kingdom | 32 | 32.32% |
Portugal | 12 | 12.12% |
Denmark | 9 | 9.09% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Melanie Lee
- Personal Network